BioSpace News Archive

Forecast to 2030,’ thoroughly examines the Duchenne Muscular Dystrophy industry to provide essential data & information for the targeted readers.

Forecast to 2030,’ thoroughly examines the Bronchiectasis Treatment industry to provide essential data & information for the targeted readers.

Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), today announced the closing on July 28, 2022 of its previously announced public offering of 8,333,334 shares of its common stock, together with warrants to purchase up to 8,333,334 shares of its common stock at an offering price to the public of $0.60 per share and associated warrant.

T2 Biosystems, Inc. a leader in the rapid detection of sepsis-causing pathogens, announced that it issued inducement awards to twelve new employees.

Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, announced that the U.S. Food and Drug Administration has approved the New Drug Application for ZORYVE cream 0.3% for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older.

Evaxion Biotech A/S, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announced that it will present its second-quarter 2022 financial results on August 10 at 8.30 a.m. EDT.

, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities.

PrecisemAb Biotech, a biotechnology research company based in Kaohsiung, Taiwan, continues to stay true to its vision of enhancing antibody drugs by reducing side effects through the patented Universal Antibody Lock technology.

Wilmington, Delaware, United States, Transparency Market Research Inc.: A significant ascent in the reception of stream cytometry methods in the clinical preliminaries and exploration exercises is projected to empower the development of the worldwide stream cytometry market in the coming years.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The rising incidences of chronic diseases across the globe are likely to create immense growth opportunities for the electrosurgery market during the forecast period of 2021-2031.